Rakeshchandra Jagdishprasad Sinha
About Rakeshchandra Jagdishprasad Sinha
Data last updated:
Rakeshchandra Jagdishprasad Sinha is a Director at Sun Pharma Distributors Limited (since 2019), Director at Sun Pharma Laboratories Limited (since 2024) and Director at Softdeal Pharmaceutical Private Limited (since 2019), and holds 8 more current directorships. The companies operate in Pharma, Real Estate and Construction and Chemicals. The 7 current companies with reported revenue have a combined latest revenue of ₹29,969 Cr; the largest is Sun Pharma Distributors Limited at ₹16,887 Cr (FY 2025). Earlier, Rakeshchandra Jagdishprasad Sinha was an Additional Director at Realstone Multitrade Private Limited (2019) and Additional Director at Pharmarack Technologies Private Limited (2021) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sun Pharma Distributors Limited U51909MH2019PLC322778 | Director | 19 Mar 2019 | 2019 | ₹16,887 Cr (FY 2025) | Active |
 Sun Pharma Laboratories Limited U25200GJ1997PLC133846 | Director | 23 Apr 2024 | 1997 | ₹12,715 Cr (FY 2024) | Active |
 Softdeal Pharmaceutical Private Limited U51900MH2006PTC159237 | Director | 19 Apr 2019 | 2006 | ₹235 Cr (FY 2025) | Active |
 Innovcare Lifesciences Private Limited U74999MH2014PTC256233 | Director | 06 Jul 2026 | 2014 | ₹87.72 Cr (FY 2025) | Active |
 Zenotech Laboratories Limited L27100TG1989PLC010122 | Director | 01 Feb 2020 | 1989 | ₹44.60 Cr (FY 2025) | Active |
| Neetnav Real Estate Private Limited U45200MH2010PTC201611 | Director | 19 Apr 2019 | 2010 | ₹19.2 Lakh (FY 2025) | Active |
| Faststone Mercantile Company Private Limited U51900GJ2006PTC133844 | Director | 19 Apr 2019 | 2006 | ₹1.2 Lakh (FY 2023) | Active |
| Caraco Pharmaceuticals Private Limited U24100MH2012FTC225970 | Director | 29 Jan 2024 | 2012 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Realstone Multitrade Private Limited U51900GJ2006PTC133238 | Additional Director | 19 Apr 2019 | 2006 | ₹74,348 (FY 2022) | Amalgamated |
 Pharmarack Technologies Private Limited U72900PN2015PTC156535 | Additional Director | 26 Aug 2021 | 2015 | ₹45.34 Cr (FY 2024) | Active |
| Skisen Labs Private Limited U73100GJ2005PTC133239 | Cfo | 01 Nov 2020 | 2005 | Amalgamated | |
| Foundation For Pharmaceutical Academy For Global Excellence U85303MH2024NPL421811 | Director | 20 Mar 2024 | 2024 | Active | |
| Green Eco Development Centre Limited U90009GJ2010PLC062892 | Additional Director | 28 Mar 2019 | 2010 | ₹16,000 (FY 2023) | Amalgamated |
 Sun Pharmaceutical Medicare Limited U36900GJ2017PLC095132 | Director | 19 Apr 2019 | 2017 | ₹419 Cr (FY 2025) | Amalgamated |
 Pharmasofttech Awacs Private Limited U74900MH2007PTC174358 | Director | 26 Aug 2021 | 2007 | ₹20.07 Cr (FY 2022) | Amalgamated |
| Magna Carta Legal Solutions Private Limited U74999MH2015PTC271423 | Director | 30 Dec 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rakeshchandra Jagdishprasad Sinha
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakeshchandra Jagdishprasad Sinha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakeshchandra Jagdishprasad Sinha
Rakeshchandra Jagdishprasad Sinha currently holds 11 directorships: Sun Pharma Distributors Limited (Director, since 19 Mar 2019, revenue ₹16,887 Cr (FY 2025)); Sun Pharma Laboratories Limited (Director, since 23 Apr 2024, revenue ₹12,715 Cr (FY 2024)); Softdeal Pharmaceutical Private Limited (Director, since 19 Apr 2019, revenue ₹235 Cr (FY 2025)); Innovcare Lifesciences Private Limited (Director, since 06 Jul 2026, revenue ₹87.72 Cr (FY 2025)); Zenotech Laboratories Limited (Director, since 01 Feb 2020, revenue ₹44.60 Cr (FY 2025)); and 6 more.
Rakeshchandra Jagdishprasad Sinha was first appointed on 30 Dec 2015 as Director at Magna Carta Legal Solutions Private Limited. The most recent appointment on record is 06 Jul 2026 at Innovcare Lifesciences Private Limited.
The 7 current companies of Rakeshchandra Jagdishprasad Sinha that report revenue have a combined latest revenue of ₹29,969 Cr: Sun Pharma Distributors Limited ₹16,887 Cr (FY 2025); Sun Pharma Laboratories Limited ₹12,715 Cr (FY 2024); Softdeal Pharmaceutical Private Limited ₹235 Cr (FY 2025); Innovcare Lifesciences Private Limited ₹87.72 Cr (FY 2025); Zenotech Laboratories Limited ₹44.60 Cr (FY 2025); and 2 more.
Rakeshchandra Jagdishprasad Sinha held 8 earlier board appointments: Realstone Multitrade Private Limited (Additional Director, 19 Apr 2019 to 30 Sep 2019); Pharmarack Technologies Private Limited (Additional Director, 26 Aug 2021 to 30 Oct 2021); Skisen Labs Private Limited (Cfo, 01 Nov 2020 to 31 Jul 2021); Foundation For Pharmaceutical Academy For Global Excellence (Director, 20 Mar 2024 to 06 May 2025); Green Eco Development Centre Limited (Additional Director, 28 Mar 2019 to 30 Sep 2019); and 3 more.
The current boards of Rakeshchandra Jagdishprasad Sinha's companies include Kirti Wardhaman Ganorkar (Sun Pharma Distributors Limited), Rama Bijapurkar (Sun Pharma Distributors Limited), Chinnadharavaram Sundaresan Muralidharan (Sun Pharma Laboratories Limited), Gautam Bhailal Doshi (Sun Pharma Laboratories Limited), Jayashree Satagopan (Sun Pharma Laboratories Limited), Kirti Wardhaman Ganorkar (Sun Pharma Laboratories Limited), among others.